---
figid: PMC5945496__oncotarget-09-20508-g006
figlink: /pmc/articles/PMC5945496/figure/F6/
number: F6
caption: Left, in normal conditions, NRF2 is bound by its inhibitor Keap1 and it is
  directed for proteasomal degradation. Upon activation (e.g. oncogenes, oxidative
  stress), NRF2 translocates into the nucleus where it binds to ARE (antioxidant responsive
  element) sequences within promoters of target genes. Right, mutant p53, when expressed,
  selectively activates NRF2 downstream targets, thioredoxin and proteasome systems.
  This effects in acquiring the resistance to microenvironmental stress. At the same
  time mutant p53 by increasing the presence of NRF2 on the gene promoters of TXN
  or TXNRD1 sequesters NRF2 from canonical NRF2 regulatory elements of other NRF2
  targets (e.g. HMOX1).
pmcid: PMC5945496
papertitle: Mutant p53 tunes the NRF2-dependent antioxidant response to support survival
  of cancer cells.
reftext: Kamil Lisek, et al. Oncotarget. 2018 Apr 17;9(29):20508-20523.
pmc_ranked_result_index: '17988'
pathway_score: 0.9520018
filename: oncotarget-09-20508-g006.jpg
figtitle: Mutant p53 tunes the NRF2-dependent antioxidant response to support survival
  of cancer cells
year: '2018'
organisms:
- Homo sapiens
ndex: c31723fb-deb2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5945496__oncotarget-09-20508-g006.html
  '@type': Dataset
  description: Left, in normal conditions, NRF2 is bound by its inhibitor Keap1 and
    it is directed for proteasomal degradation. Upon activation (e.g. oncogenes, oxidative
    stress), NRF2 translocates into the nucleus where it binds to ARE (antioxidant
    responsive element) sequences within promoters of target genes. Right, mutant
    p53, when expressed, selectively activates NRF2 downstream targets, thioredoxin
    and proteasome systems. This effects in acquiring the resistance to microenvironmental
    stress. At the same time mutant p53 by increasing the presence of NRF2 on the
    gene promoters of TXN or TXNRD1 sequesters NRF2 from canonical NRF2 regulatory
    elements of other NRF2 targets (e.g. HMOX1).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BRAF
  - KEAP1
  - SLC7A11
  - HRAS
  - MYC
  - ABCC3
  - PSMC1
  - PSMA2
  - HMOX1
  - TXNRD1
  - TXN
  - GCLM
  - SFN
  - carfilzomib
  - bortezomib
  - SFN
genes:
- word: (HRAS,BRAF,c-MYC),
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Keap1
  symbol: KEAP1
  source: hgnc_symbol
  hgnc_symbol: KEAP1
  entrez: '9817'
- word: E.g.HMOX1,SLC7A11,
  symbol: SLC7A11
  source: hgnc_symbol
  hgnc_symbol: SLC7A11
  entrez: '23657'
- word: (HRAS,
  symbol: HRAS
  source: hgnc_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: (HRAS,BRAF,c-MYC),
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: ABCC3
  symbol: ABCC3
  source: hgnc_symbol
  hgnc_symbol: ABCC3
  entrez: '8714'
- word: PSMA2,PSMC1,
  symbol: PSMC1
  source: hgnc_symbol
  hgnc_symbol: PSMC1
  entrez: '5700'
- word: PSMA2,
  symbol: PSMA2
  source: hgnc_symbol
  hgnc_symbol: PSMA2
  entrez: '5683'
- word: HMOX1
  symbol: HMOX1
  source: hgnc_symbol
  hgnc_symbol: HMOX1
  entrez: '3162'
- word: TXNRD1
  symbol: TXNRD1
  source: hgnc_symbol
  hgnc_symbol: TXNRD1
  entrez: '7296'
- word: TXN/
  symbol: TXN
  source: hgnc_symbol
  hgnc_symbol: TXN
  entrez: '7295'
- word: E.g.TXN,TXNRD1,GCLM,
  symbol: GCLM
  source: hgnc_symbol
  hgnc_symbol: GCLM
  entrez: '2730'
- word: (tBHQ,SFN)
  symbol: SFN
  source: hgnc_symbol
  hgnc_symbol: SFN
  entrez: '2810'
chemicals:
- word: carfilzomib
  source: MESH
  identifier: C524865
- word: bortezomib
  source: MESH
  identifier: C400082
- word: SFN
  source: MESH
  identifier: C413442
diseases: []
figid_alias: PMC5945496__F6
redirect_from: /figures/PMC5945496__F6
figtype: Figure
---
